Gema Mateo

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

Ernesto Pérez Persona, María‐Belén Vídriales, Gema Mateo et al. · Blood · 2007 · 575 citations · Full text

Medicine, Hematology, Pathology +17

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

Andy C. Rawstron, Meral Beksaç, Ludmila Bezdîčková et al. · Haematologica · 2008 · 514 citations · Full text

Medicine, Hematology, Pathology +17

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

Bruno Paiva, María‐Belén Vídriales, Jorge Cerveró et al. · Blood · 2008 · 475 citations · Full text

Medicine, Hematology, Immunology +17

The Histone Deacetylase Inhibitor LBH589 Is a Potent Antimyeloma Agent that Overcomes Drug Resistance

Patricia Maiso, Xonia Carvajal‐Vergara, Enrique M. Ocio et al. · Cancer Research · 2006 · 241 citations

Medicine, Oncology, Pharmacology +17

Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy

Gema Mateo, María-Ángeles Montalbán, María‐Belén Vídriales et al. · Journal of Clinical Oncology · 2008 · 210 citations · Full text

Medicine, Hematology, Oncology +16